Vaxar 75 Capsule

About Vaxar 75 Capsule

Vaxar 75 is a 75 mg capsule made by Nuvista Pharma Ltd. It contains pregabalin and is used as an add-on treatment in certain nerve pain and seizure conditions. A doctor decides whether it suits you and how it should be taken.

There are 105 brands of Pregabalin listed in Bangladesh. The lowest listed price is GAPA-P 150 mg Capsule at ৳ 1 per unit.

What is Vaxar 75 Capsule?

Vaxar 75 is a capsule containing 75 mg of pregabalin, supplied by Nuvista Pharma Ltd. Pregabalin belongs to a group of medicines used as add-on anti-epileptic drugs. Doctors prescribe it for nerve pain linked to diabetes, pain after shingles, fibromyalgia and nerve pain from spinal cord injury, and as add-on therapy for some partial-onset seizures. It works in the central nervous system, though its exact action is not fully understood. Only a doctor can decide if it is appropriate for you, and the dose and course are always set by the doctor.

Uses of Vaxar 75

Vaxar 75 is used in adults for certain types of nerve pain, including nerve pain from diabetic peripheral neuropathy, pain after shingles (postherpetic neuralgia), fibromyalgia, and nerve pain linked to spinal cord injury. It is also used as add-on therapy for partial-onset seizures in some patients. Whether it is right for your condition is a decision for your doctor.

How to use Vaxar 75

Take Vaxar 75 exactly as your doctor tells you. The dose and how long you take it are decided by the doctor based on your condition and response. Swallow the capsule as directed, and do not change the dose or stop it on your own, since stopping suddenly can cause problems. If you miss a dose or are unsure how to take it, ask your doctor or pharmacist.

Side effects of Vaxar 75

Common side effects in adults include dizziness, drowsiness, dry mouth, swelling, blurred vision, weight gain and difficulty concentrating. In children treated for partial-onset seizures, increased weight and increased appetite are common. Some people may have serious reactions such as swelling of the throat, head and neck, allergic reactions, or breathing problems, especially with other medicines that affect the brain. Seek medical help for severe symptoms and tell your doctor about any side effect.

Safety and precautions

Do not take Vaxar 75 if you are allergic to pregabalin or any of its ingredients. Tell your doctor if you have breathing problems or take medicines that affect the brain, as these can raise the risk of breathing problems. Antiepileptic medicines like this one can increase the risk of suicidal thoughts or behaviour, so tell your doctor about changes in mood. There are no adequate studies in pregnant women, so pregnancy should be discussed with the doctor. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment. Ask your doctor before starting if you are pregnant, planning pregnancy or breastfeeding.

Frequently asked questions

How should Vaxar 75 be taken?

The dose and how often you take it are decided by your doctor, based on your condition and how you respond. Follow the doctor's instructions exactly and do not change or stop the medicine on your own. Ask your doctor or pharmacist if anything is unclear.

What is Vaxar 75 used for and what kind of medicine is it?

Vaxar 75 contains pregabalin, an add-on anti-epileptic medicine. It is used for certain nerve pain conditions such as diabetic nerve pain, pain after shingles, fibromyalgia and spinal cord injury nerve pain, and as add-on therapy for some partial-onset seizures. Your doctor will decide if it is suitable for you.

Is Vaxar 75 safe in pregnancy or breastfeeding?

There are no adequate studies of pregabalin in pregnant women, so the possible risk to an unborn baby should be discussed with your doctor. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding.

Can I stop taking Vaxar 75 on my own?

No. The course and any changes are decided by your doctor. Stopping suddenly or changing the dose without advice can cause problems. Speak to your doctor before making any change, and ask your pharmacist if you have questions about how to take it.

Indications

Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
  • ... Read more
Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
Pregabalin CR tablet is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)

Pharmacology

Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.

Dosage & Administration

Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.

Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).

Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.

Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).

Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.

Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.

Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
  • 75 mg/daily: 82.5 mg/day
  • 150 mg/daily: 165 mg/day
  • 225 mg/daily: 247.5 mg/day
  • 300 mg/daily: 330 mg/day
  • 450 mg/daily: 495 mg/day
  • 600 mg/daily: 660 mg/day

Interaction

Pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions.

Contraindications

Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.

Side Effects

Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.

Pregnancy & Lactation

There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.

Precautions & Warnings

Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Pregabalin should be discontinued immediately in these cases. Pregabalin should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with pregabalin when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Pregabalin may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if pregabalin is rapidly discontinued. Pregabalin should be withdrawn gradually over a minimum of 1 week. Pregabalin may cause peripheral edema. Caution should be exercised when coadministering pregabalin and thiazolidinedione antidiabetic agents.

Overdose Effects

In case of overdose with pregabalin, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.

Storage Conditions

Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.

Alternative brands of Pregabalin

Other brands with the same generic name, cheapest first.

Gabarol Capsule

25 mg

Pregabalin

Advanced Chemical Industries PLC

৳ 11.00 per unit

Algaba Capsule

50 mg

Pregabalin

Al-Madina Pharmaceuticals Ltd.

৳ 12.00 per unit

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.